Literature DB >> 26208401

Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.

Moses Tam1, Nadeem Riaz, Danita Kannarunimit, Angela P Peña, Karen D Schupak, Daphna Y Gelblum, Suzanne L Wolden, Shyam Rao, Nancy Y Lee.   

Abstract

OBJECTIVES: To assess whether sparing neck-level IB in target delineation of node-positive (N+) oropharyngeal carcinoma (OPC) can improve xerostomia outcomes without compromising locoregional control (LRC).
METHODS: A total of 125 N+ OPC patients with a median age of 57 years underwent chemoradiation between May 2010 and December 2011. A total of 74% of patients had T1-T2 disease, 26% T3-T4, 16% N1, 8% N2A, 48% N2B, 28% N2C; 53% base of tongue, 41% tonsil, and 6% other. Patients were divided into those who had target delineation sparing of bilateral level IB (the spared cohort) versus no sparing (the treated cohort). Sparing of contralateral high-level II nodes was also performed more consistently in the spared cohort. A prospective xerostomia questionnaire (patient reported) was given at each patient follow-up visit to this cohort of patients to assess late xerostomia. Clinical assessment (observer rated) at each patient follow-up visit was also recorded.
RESULTS: The 2-year LRC for the spared and treated cohorts was 97.5% and 93.8%, respectively (median follow-up, 23.2 mo). No locoregional failures occurred outside of treatment fields. The spared cohort experienced significant benefits in patient-reported xerostomia summary scores (P=0.021) and observer-rated xerostomia scores (P=0.006). In addition, there were significant reductions in mean doses to the ipsilateral submandibular gland (63.9 vs. 70.5 Gy; P<0.001), contralateral submandibular gland (45.0 vs. 56.2 Gy; P<0.001), oral cavity (35.9 vs. 45.2 Gy; P<0.001), and contralateral parotid gland (20.0 vs. 24.4 Gy; P<0.001).
CONCLUSIONS: Target delineation sparing of bilateral level IB nodes in N+ OPC reduced mean doses to salivary organs without compromising LRC. Patients with reduced target volumes had better patient-reported xerostomia outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26208401      PMCID: PMC5508539          DOI: 10.1097/COC.0000000000000064

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  20 in total

1.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

Authors:  Vincent Grégoire; Peter Levendag; Kian K Ang; Jacques Bernier; Marijel Braaksma; Volker Budach; Cliff Chao; Emmanuel Coche; Jay S Cooper; Guy Cosnard; Avraham Eisbruch; Samy El-Sayed; Bahman Emami; Cai Grau; Marc Hamoir; Nancy Lee; Philippe Maingon; Karin Muller; Hervé Reychler
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280

2.  A pragmatic contouring guideline for salivary gland structures in head and neck radiation oncology: the MOIST target.

Authors:  Frank Hoebers; Eugene Yu; Avi Eisbruch; Wade Thorstad; Brian O'Sullivan; Laura A Dawson; Andrew Hope
Journal:  Am J Clin Oncol       Date:  2013-02       Impact factor: 2.339

Review 3.  Radiotherapy dose-volume effects on salivary gland function.

Authors:  Joseph O Deasy; Vitali Moiseenko; Lawrence Marks; K S Clifford Chao; Jiho Nam; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

4.  Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.

Authors:  Michael Little; Matthew Schipper; Felix Y Feng; Karen Vineberg; Craig Cornwall; Carol-Anne Murdoch-Kinch; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-04       Impact factor: 7.038

5.  The relative contributions of different salivary glands to the blood group activity of whole saliva in humans.

Authors:  R W Milne; C Dawes
Journal:  Vox Sang       Date:  1973-10       Impact factor: 2.144

6.  Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

Authors:  Fernando F de Arruda; Dev R Puri; Joanne Zhung; Ashwatha Narayana; Suzanne Wolden; Margie Hunt; Hilda Stambuk; David Pfister; Dennis Kraus; Ashok Shaha; Jatin Shah; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-05-31       Impact factor: 7.038

7.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.

Authors:  A Eisbruch; H M Kim; J E Terrell; L H Marsh; L A Dawson; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

8.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.

Authors:  Jeremy Setton; Nicola Caria; Jonathan Romanyshyn; Lawrence Koutcher; Suzanne L Wolden; Michael J Zelefsky; Nicholas Rowan; Eric J Sherman; Matthew G Fury; David G Pfister; Richard J Wong; Jatin P Shah; Dennis H Kraus; Weiji Shi; Zhigang Zhang; Karen D Schupak; Daphna Y Gelblum; Shyam D Rao; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-16       Impact factor: 7.038

9.  Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.

Authors:  Carol-Anne Murdoch-Kinch; Hyugnjin M Kim; Karen A Vineberg; Jonathan A Ship; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-11       Impact factor: 7.038

10.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.

Authors:  Avraham Eisbruch; Lon H Marsh; Laura A Dawson; Carol R Bradford; Theodoros N Teknos; Douglas B Chepeha; Francis P Worden; Susan Urba; Alexander Lin; Matthew J Schipper; Gregory T Wolf
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

View more
  3 in total

1.  Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.

Authors:  Jonathan E Leeman; Jin-Gao Li; Xin Pei; Praveen Venigalla; Zachary S Zumsteg; Evangelia Katsoulakis; Eitan Lupovitch; Sean M McBride; Chiaojung J Tsai; Jay O Boyle; Benjamin R Roman; Luc G T Morris; Lara A Dunn; Eric J Sherman; Nancy Y Lee; Nadeem Riaz
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

2.  Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.

Authors:  Nadeem Riaz; Eric Sherman; Xin Pei; Heiko Schöder; Milan Grkovski; Ramesh Paudyal; Nora Katabi; Pier Selenica; Takafumi N Yamaguchi; Daniel Ma; Simon K Lee; Rachna Shah; Rahul Kumar; Fengshen Kuo; Abhirami Ratnakumar; Nathan Aleynick; David Brown; Zhigang Zhang; Vaios Hatzoglou; Lydia Y Liu; Adriana Salcedo; Chiaojung J Tsai; Sean McBride; Luc G T Morris; Jay Boyle; Bhuvanesh Singh; Daniel S Higginson; Rama R Damerla; Arnaud da Cruz Paula; Katharine Price; Eric J Moore; Joaquin J Garcia; Robert Foote; Alan Ho; Richard J Wong; Timothy A Chan; Simon N Powell; Paul C Boutros; John L Humm; Amita Shukla-Dave; David Pfister; Jorge S Reis-Filho; Nancy Lee
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

3.  Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.

Authors:  Michael F Gensheimer; Matthew Nyflot; George E Laramore; Jay J Liao; Upendra Parvathaneni
Journal:  Radiat Oncol       Date:  2016-11-15       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.